# Chrysin ameliorates methotrexate-induced hippocampal neurogenesis impairment by suppressing of oxidative stress and upregulating antioxidant enzyme activity in rodents

**Authors:** Tanaporn Anosri, Soraya Kaewngam, Ram Prajit, Kornrawee Suwannakot, Nataya Sritawan, Anusara Aranarochana, Wanassanan Pannangrong, Jariya Umka Welbat, Peter Wigmore, Apiwat Sirichoat

PMC · DOI: 10.1371/journal.pone.0342921 · PLOS One · 2026-02-17

## TL;DR

Chrysin helps protect the brain from methotrexate's harmful effects by reducing oxidative stress and boosting antioxidant activity in rats.

## Contribution

This study demonstrates chrysin's neuroprotective effects against methotrexate-induced neurogenesis impairment in rodents.

## Key findings

- Methotrexate reduced antioxidant enzyme activity and caused oxidative stress in rats.
- Chrysin reversed methotrexate's negative effects on neurogenesis and antioxidant enzyme activity.
- Chrysin improved the expression of proteins related to neurogenesis and antioxidant pathways.

## Abstract

Methotrexate (MTX) is used in treating several malignancies. However, MTX neurotoxicity remains a significant clinical side effect, leading to cell division malformation, and neurogenesis impairment. Chrysin, a flavonoid compound found in natural products, demonstrates various biological characteristics, including neuroprotective and antioxidant properties. The purpose of this study was to investigate the ameliorative effect of chrysin on oxidative damage and neurogenesis impairment caused by MTX. Male Sprague-Dawley rats were randomly divided into four groups, including the vehicle, MTX (75 mg/kg), chrysin (10 mg/kg), and chrysin+MTX groups. Chrysin was orally administered for 15 days. MTX was administered intravenously on days 8 and 15. The hippocampal neural stem cells were evaluated using sex determining region Y-box 2 (sox2) and nestin immunofluorescence staining. Antioxidant enzyme expression and the levels of oxidative stress marker were assessed. Additionally, the expressions of nuclear factor erythroid 2-related factor 2 (Nrf2), brain-derived neurotrophic factor (BDNF), cAMP-response element binding (CREB), and phosphorylated CREB (pCREB) were evaluated using Western blotting. Results showed that MTX significantly decreased the activity of antioxidant enzymes and produced oxidative stress. MTX also impaired neurogenesis, evidenced by decreased sox2 and nestin-positive cells and decreased expression of Nrf2, BDNF, CREB, and pCREB in the hippocampus and prefrontal cortex. However, chrysin significantly reversed the effects of MTX on these parameters. In conclusion, chrysin exhibits neuroprotective effects against MTX-induced neurogenesis impairment by upregulating antioxidant enzyme activity, reducing oxidative stress, and improving protein expression related to neurogenesis.

## Linked entities

- **Genes:** SOX2 (SRY-box transcription factor 2) [NCBI Gene 6657], GABPA (GA binding protein transcription factor subunit alpha) [NCBI Gene 2551], BDNF (brain derived neurotrophic factor) [NCBI Gene 627], CREB1 (cAMP responsive element binding protein 1) [NCBI Gene 1385]
- **Proteins:** BDNF (brain derived neurotrophic factor), GABPA (GA binding protein transcription factor subunit alpha), CREB1 (cAMP responsive element binding protein 1)
- **Chemicals:** Methotrexate (PubChem CID 4112), Chrysin (PubChem CID 5281607)

## Full-text entities

- **Genes:** Prkcg (protein kinase C, gamma) [NCBI Gene 24681] {aka PKC, PKCI, Prkc, Prkcc, RATPKCI}, Bdnf (brain derived neurotrophic factor) [NCBI Gene 12064], DHFR (dihydrofolate reductase) [NCBI Gene 1719] {aka DHFR1, DYR}, Bdnf (brain-derived neurotrophic factor) [NCBI Gene 24225], Nes (nestin) [NCBI Gene 18008] {aka ESTM46, Ifaprc2, Marc2, RC2}, Gsr (glutathione-disulfide reductase) [NCBI Gene 116686], Sox2 (SRY-box transcription factor 2) [NCBI Gene 499593] {aka RGD1565646}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, Esr1 (estrogen receptor 1) [NCBI Gene 24890] {aka ER-alpha, Esr, RNESTROR}, Esr2 (estrogen receptor 2) [NCBI Gene 25149] {aka ER-beta, ERbeta, Erb2}, Cat (catalase) [NCBI Gene 24248] {aka CS1, Cas1, Cat01, Catl, Cs-1}, Irs1 (insulin receptor substrate 1) [NCBI Gene 25467] {aka IRS1IRM}, Pik3cb (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta) [NCBI Gene 85243], Ntrk2 (neurotrophic receptor tyrosine kinase 2) [NCBI Gene 25054] {aka RATTRKB1, TRKB1, Tkrb, trk-B, trkB}, SOX2 (SRY-box transcription factor 2) [NCBI Gene 6657] {aka ANOP3, MCOPS3}, Nfe2l2 (nuclear factor, erythroid derived 2, like 2) [NCBI Gene 18024] {aka Nrf2}, Nfe2l2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 83619], Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Creb1 (cAMP responsive element binding protein 1) [NCBI Gene 12912] {aka 2310001E10Rik, 3526402H21Rik, Creb, Creb-1}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, CREB1 (cAMP responsive element binding protein 1) [NCBI Gene 1385] {aka CREB, CREB-1}, Keap1 (Kelch-like ECH-associated protein 1) [NCBI Gene 117519] {aka Inrf2}, Akt1 (AKT serine/threonine kinase 1) [NCBI Gene 24185] {aka Akt}, Creb1 (cAMP responsive element binding protein 1) [NCBI Gene 81646] {aka Creb}, Sox2 (SRY (sex determining region Y)-box 2) [NCBI Gene 20674] {aka Sox-2, lcc, ysb}
- **Diseases:** learning and memory impairment (MESH:D007859), central nervous system toxicity (MESH:D002493), neurotoxic (MESH:D020258), memory decline (MESH:D060825), cancer (MESH:D009369), inflammatory (MESH:D007249), neurodegenerative disorders (MESH:D019636), cognitive impairment (MESH:D003072), memory deficits (MESH:D008569), dislocation (MESH:D004204), brain injury (MESH:D001930)
- **Chemicals:** NO (MESH:D009569), xanthine (MESH:D019820), aldehyde (MESH:D000447), LCV (MESH:C475159), SDS (MESH:D012967), 5,5'-Dithiobis-(2-nitrobenzoic acid (MESH:D004228), acetic acid (MESH:D019342), Leucovorin (MESH:D002955), thiobarbituric acid (MESH:C029684), water (MESH:D014867), IP3 (MESH:D015544), sodium azide (MESH:D019810), MTX (MESH:D008727), polyacrylamide (MESH:C016679), potassium phosphate (MESH:C013216), nitrogen (MESH:D009584), ethylenediaminetetraacetic acid (MESH:D004492), oxygen (MESH:D010100), 5, 7-Dihydroxyflavone (MESH:C043561), EGCG (MESH:C045651), flavonoid (MESH:D005419), DAPI (MESH:C007293), calcium (MESH:D002118), sulfuric acid (MESH:C033158), folate (MESH:D005492), tween-20 (MESH:D011136), DAG (MESH:D004075), lipid (MESH:D008055), sucrose (MESH:D013395), 1,1,3,3-Tetraethoxypropane (MESH:C022168), glutathione (MESH:D005978), tetrahydro folic acid (MESH:C030371), propylene glycol (MESH:D019946), Alexa Fluor 488 (MESH:C000711379), MDA (MESH:D008315), potassium permanganate (MESH:D011196), propolis (MESH:D011429), pyridine (MESH:C023666), PUFA (MESH:D005231), sodium phosphate (MESH:C018279), n-Butanol (MESH:D020001), Alexa Fluor 568 (-), H2O2 (MESH:D006861), propidium iodide (MESH:D011419)
- **Species:** Pelargonium crispum (species) [taxon 1417776], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Oroxylum indicum (broken bones plant, species) [taxon 83951], Passiflora incarnata (species) [taxon 159425]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12912610/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12912610/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC12912610/full.md

---
Source: https://tomesphere.com/paper/PMC12912610